Search
for
Sort by
Research 91–120 of 1000+
- Nemolizumab Treatment for Severe Atopic Dermatitis Led to the Simultaneous Improvement of Coexisting Refractory Alopecia Areata: A Case Report
- Androgenic Alopecia Is Associated With More Severe Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
- A Paediatric Case of Severe Allergic Conjunctivits with Underlying Alopecia Areata
- Alopecia areata after severe allergic contact dermatitis to a permanent hair dye
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Efficacy and tolerability of methotrexate in severe childhood alopecia areata
- Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study
- Oral tofacitinib monotherapy in Korean patients with refractory moderate-to-severe alopecia areata: A case series
- Tofacitinib therapy for children with severe alopecia areata
- Ruxolitinib for the treatment of severe alopecia areata
- The effect of oral cyclosporine in the treatment of severe alopecia areata
- Immunohistochemical Characterization of the Cellular Infiltrate in Severe Alopecia areata before and after Minoxidil Treatment
- Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents
- 3 percent topical minoxidil compared with placebo for the treatment of chronic severe alopecia areata.
- Combination tofacitinib and oral minoxidil treatment for severe alopecia areata
- Lack of efficacy of apremilast in 9 patients with severe alopecia areata
- Homozygous Dominant Missense Mutation in Keratin 17 Leads to Alopecia in Addition to Severe Pachyonychia Congenita
- Early Intervention with High-Dose Steroid Pulse Therapy Prolongs Disease-Free Interval of Severe Alopecia Areata: A Retrospective Study
- Low-dose tofacitinib for treating patients with severe alopecia areata: an efficient and cost-saving regimen
- Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study
- Experience with oral tofacitinib in severe alopecia areata with different clinical responses
- Efficacy and safety of tofacitinib therapy in Asian patients with severe alopecia areata
- Nail involvement in patients with moderate-to-severe alopecia areata treated with oral tofacitinib
- Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study
- Upadacitinib for the management of severe alopecia areata in adolescent patients: a single-centre retrospective study
- Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment
- Comparative efficacy and safety of systemic steroids, oral JAK inhibitors and Contact Immunotherapy in the Treatment of severe alopecia areata: a systematic review and network meta-analysis
- Scalp hair regrowth is associated with improvements in health-related quality of life and psychological symptoms in patients with severe alopecia areata: results from two randomized controlled trials
- Alefacept for Severe Alopecia Areata: A Randomized, Double-blind, Placebo-Controlled Study
- 41701 Efficacy of the Oral JAK1/JAK2 Inhibitor CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata: Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 Phase 3 Trial